| scholarly article | Q13442814 |
| P50 | author | Xiaoming Lyu | Q60984544 |
| P2093 | author name string | Xin Li | |
| Ying Wang | |||
| Xiaona Zhang | |||
| Jianguo Wang | |||
| Yuxiang Chen | |||
| Jinbang Li | |||
| Longmei Cai | |||
| Hongbing Cai | |||
| Yaoyong Lu | |||
| Jinkun Liu | |||
| P2860 | cites work | The viral and cellular microRNA targetome in lymphoblastoid cell lines | Q21131404 |
| An Epstein-Barr virus-encoded microRNA targets PUMA to promote host cell survival | Q24649032 | ||
| Identification of virus-encoded microRNAs | Q28259309 | ||
| The Epstein-Barr virus-encoded microRNA MiR-BART9 promotes tumor metastasis by targeting E-cadherin in nasopharyngeal carcinoma | Q28540190 | ||
| Multiple roles of the PI3K/PKB (Akt) pathway in cell cycle progression | Q28679187 | ||
| Therapeutic silencing of microRNA-122 in primates with chronic hepatitis C virus infection | Q29615959 | ||
| Analysis of BART7 microRNA from Epstein-Barr virus-infected nasopharyngeal carcinoma cells by capillary electrophoresis | Q33376827 | ||
| TGFβR2 is a major target of miR-93 in nasopharyngeal carcinoma aggressiveness | Q33592822 | ||
| Epstein-Barr virus-encoded LMP2A induces an epithelial-mesenchymal transition and increases the number of side population stem-like cancer cells in nasopharyngeal carcinoma | Q33598586 | ||
| EBV-miR-BART1 is involved in regulating metabolism-associated genes in nasopharyngeal carcinoma | Q39150231 | ||
| Overexpression of Epstein-Barr virus-encoded microRNA-BART7 in undifferentiated nasopharyngeal carcinoma | Q39306381 | ||
| DYRK2 priming phosphorylation of c-Jun and c-Myc modulates cell cycle progression in human cancer cells | Q39401250 | ||
| RASSF1A suppresses the c-Jun-NH2-kinase pathway and inhibits cell cycle progression | Q40427754 | ||
| MicroRNA-92a functions as an oncogene in colorectal cancer by targeting PTEN. | Q41412784 | ||
| Good things come in small packages: Therapeutic anti-tumor immunity induced by microRNA nanoparticles | Q41474711 | ||
| An orthotopic model of metastatic nasopharyngeal carcinoma and its application in elucidating a therapeutic target that inhibits metastasis | Q41865036 | ||
| Long-term results of concurrent chemoradiotherapy for T3/T4 locally advanced nasopharyngeal carcinoma | Q41923470 | ||
| Diagnostic significance of combined detection of Epstein-Barr virus antibodies, VCA/IgA, EA/IgA, Rta/IgG and EBNA1/IgA for nasopharyngeal carcinoma | Q42225879 | ||
| A detailed immunohistochemical analysis of the PI3K/AKT/mTOR pathway in lung cancer: correlation with PIK3CA, AKT1, K-RAS or PTEN mutational status and clinicopathological features | Q43622881 | ||
| Differential miRNA expression in repeated recurrence of nasopharyngeal carcinoma | Q44643215 | ||
| The cancer-virus cures | Q45346558 | ||
| Targeting of DICE1 tumor suppressor by Epstein-Barr virus-encoded miR-BART3* microRNA in nasopharyngeal carcinoma | Q45353248 | ||
| Layer-by-layer assembled gold nanoparticles for siRNA delivery. | Q50598283 | ||
| Prediction of disease-related microRNAs by incorporating functional similarity and common association information. | Q51093708 | ||
| A potentially functional polymorphism in the promoter region of miR-34b/c is associated with an increased risk for primary hepatocellular carcinoma. | Q53334407 | ||
| [Staging 915 cases of nasopharyngeal carcinoma after simple radical radiotherapy--checkout of Fuzhou staging system (1992)] | Q81339672 | ||
| A sequence polymorphism in miR-608 predicts recurrence after radiotherapy for nasopharyngeal carcinoma | Q86998327 | ||
| [The role of microRNAs in molecular pathology of esophageal cancer and their potential usage in clinical oncology] | Q87694613 | ||
| Downregulation of FAP suppresses cell proliferation and metastasis through PTEN/PI3K/AKT and Ras-ERK signaling in oral squamous cell carcinoma | Q33654184 | ||
| EBV microRNAs in primary lymphomas and targeting of CXCL-11 by ebv-mir-BHRF1-3 | Q33793531 | ||
| Viral oncolysis - can insights from measles be transferred to canine distemper virus? | Q33820717 | ||
| Epigenetic inactivation of microRNA-34b/c predicts poor disease-free survival in early-stage lung adenocarcinoma. | Q34165233 | ||
| Targeting Epstein-Barr virus oncoprotein LMP1-mediated glycolysis sensitizes nasopharyngeal carcinoma to radiation therapy | Q34171822 | ||
| Nanoparticles modified with tumor-targeting scFv deliver siRNA and miRNA for cancer therapy. | Q34209735 | ||
| Akt: a double-edged sword in cell proliferation and genome stability | Q34223641 | ||
| MicroRNA-101 targets EZH2, MCL-1 and FOS to suppress proliferation, invasion and stem cell-like phenotype of aggressive endometrial cancer cells | Q34227586 | ||
| Editing of Epstein-Barr virus-encoded BART6 microRNAs controls their dicer targeting and consequently affects viral latency | Q34236524 | ||
| MiR-663, a microRNA targeting p21(WAF1/CIP1), promotes the proliferation and tumorigenesis of nasopharyngeal carcinoma | Q34247536 | ||
| MiR-497 downregulation contributes to the malignancy of pancreatic cancer and associates with a poor prognosis | Q34334470 | ||
| Epstein-Barr virus BALF3 mediates genomic instability and progressive malignancy in nasopharyngeal carcinoma | Q34483687 | ||
| Odontogenic ameloblast-associated protein (ODAM) inhibits growth and migration of human melanoma cells and elicits PTEN elevation and inactivation of PI3K/AKT signaling | Q34707834 | ||
| AP-1 regulates cyclin D1 and c-MYC transcription in an AKT-dependent manner in response to mTOR inhibition: role of AIP4/Itch-mediated JUNB degradation | Q35018011 | ||
| EBV-driven LMP1 and IFN-γ up-regulate PD-L1 in nasopharyngeal carcinoma: Implications for oncotargeted therapy | Q35067875 | ||
| MiR-27a targets sFRP1 in hFOB cells to regulate proliferation, apoptosis and differentiation | Q35119958 | ||
| Hepatitis B virus induces cell proliferation via HBx-induced microRNA-21 in hepatocellular carcinoma by targeting programmed cell death protein4 (PDCD4) and phosphatase and tensin homologue (PTEN). | Q35122026 | ||
| EBV and human microRNAs co-target oncogenic and apoptotic viral and human genes during latency | Q35932258 | ||
| Oncogenic PI3K deregulates transcription and translation | Q36337966 | ||
| Epstein-Barr virus-encoded microRNA miR-BART2 down-regulates the viral DNA polymerase BALF5. | Q36457063 | ||
| Epstein-Barr virus-encoded microRNA BART15-3p promotes cell apoptosis partially by targeting BRUCE. | Q36978556 | ||
| Current view: intestinal stem cells and signaling | Q37104110 | ||
| The PTEN/PI3K/AKT signalling pathway in cancer, therapeutic implications | Q37160617 | ||
| PTEN loss represses glioblastoma tumor initiating cell differentiation via inactivation of Lgl1. | Q37207668 | ||
| Tumor suppressor PDCD4 modulates miR-184-mediated direct suppression of C-MYC and BCL2 blocking cell growth and survival in nasopharyngeal carcinoma | Q37299684 | ||
| Comparing treatment outcomes of different chemotherapy sequences during intensity modulated radiotherapy for advanced N-stage nasopharyngeal carcinoma patients. | Q37348334 | ||
| Modulation of LMP2A expression by a newly identified Epstein-Barr virus-encoded microRNA miR-BART22 | Q37399274 | ||
| Aberrantly hypermethylated Homeobox A2 derepresses metalloproteinase-9 through TBP and promotes invasion in Nasopharyngeal carcinoma | Q37420206 | ||
| MicroRNAs: potential diagnostic markers and therapeutic targets for EBV-associated nasopharyngeal carcinoma. | Q37940692 | ||
| Locally advanced nasopharyngeal carcinoma: Current and emerging treatment strategies | Q37968598 | ||
| The pathological roles of BART miRNAs in nasopharyngeal carcinoma | Q37995110 | ||
| MicroRNA-34b and MicroRNA-34c are targets of p53 and cooperate in control of cell proliferation and adhesion-independent growth | Q38298486 | ||
| EBV-miR-BART7-3p promotes the EMT and metastasis of nasopharyngeal carcinoma cells by suppressing the tumor suppressor PTEN. | Q38944897 | ||
| MicroRNA-200c inhibits apoptosis in pituitary adenoma cells by targeting the PTEN/Akt signaling pathway | Q39025402 | ||
| P433 | issue | 10 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | nanotechnology | Q11468 |
| P304 | page(s) | 7838-7850 | |
| P577 | publication date | 2015-04-01 | |
| P1433 | published in | Oncotarget | Q1573155 |
| P1476 | title | Gold nano-particles (AuNPs) carrying anti-EBV-miR-BART7-3p inhibit growth of EBV-positive nasopharyngeal carcinoma | |
| P478 | volume | 6 |
| Q100945769 | Advances in targeted therapy mainly based on signal pathways for nasopharyngeal carcinoma |
| Q37659154 | BART miRNAs: an unimaginable force in the development of nasopharyngeal carcinoma |
| Q38808086 | Comprehensive Transcriptome and Mutational Profiling of Endemic Burkitt Lymphoma Reveals EBV Type-Specific Differences |
| Q92819764 | Core-shell nanoparticles suppress metastasis and modify the tumour-supportive activity of cancer-associated fibroblasts |
| Q54241446 | Deregulation of microRNA‑31a‑5p is involved in the development of primary hypertension by suppressing apoptosis of pulmonary artery smooth muscle cells via targeting TP53. |
| Q38689675 | Direct targeting of MAPK8IP1 by miR-10a-5p is a major mechanism for gastric cancer metastasis |
| Q36561585 | EBV-miR-BART10-3p facilitates epithelial-mesenchymal transition and promotes metastasis of nasopharyngeal carcinoma by targeting BTRC |
| Q37594246 | Effects of anti-CD44 monoclonal antibody IM7 carried with chitosan polylactic acid-coated nano-particles on the treatment of ovarian cancer |
| Q37086039 | Epstein-Barr virus glycoprotein gH/gL antibodies complement IgA-viral capsid antigen for diagnosis of nasopharyngeal carcinoma |
| Q37330822 | Epstein-Barr virus-encoded miR-BART6-3p inhibits cancer cell metastasis and invasion by targeting long non-coding RNA LOC553103. |
| Q37392894 | Glutaredoxin 3 promotes nasopharyngeal carcinoma growth and metastasis via EGFR/Akt pathway and independent of ROS. |
| Q55313422 | Interplay of Viral Infection, Host Cell Factors and Tumor Microenvironment in the Pathogenesis of Nasopharyngeal Carcinoma. |
| Q53693461 | Pathobiologic Roles of Epstein-Barr Virus-Encoded MicroRNAs in Human Lymphomas. |
| Q92541244 | The Function and Therapeutic Potential of Epstein-Barr Virus-Encoded MicroRNAs in Cancer |
| Q84957624 | The Interplay Between Viral-Derived miRNAs and Host Immunity During Infection |
| Q56952019 | The emerging role of Epstein-Barr virus encoded microRNAs in nasopharyngeal carcinoma |
| Q64946489 | The regulatory network of nasopharyngeal carcinoma metastasis with a focus on EBV, lncRNAs and miRNAs. |
| Q101155923 | The roles of miRNAs and lncRNAs in Epstein-Barr virus associated epithelial cell tumors |
Search more.